| Gene Symbol | MMP14 |
| Entrez ID | 4323 |
| Uniprot ID | P50281 |
| Description | matrix metallopeptidase 14 |
| Chromosomal Location | chr14: 22,836,557-22,849,027 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
|
BP |
GO:0001525 |
angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
IEA |
|
BP |
GO:0001541 |
ovarian follicle development |
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure. |
IEA |
|
BP |
GO:0001666 |
response to hypoxia |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. |
IEA |
|
BP |
GO:0001935 |
endothelial cell proliferation |
The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium. |
IEA |
|
BP |
GO:0001958 |
endochondral ossification |
Replacement ossification wherein bone tissue replaces cartilage. |
IEA |
|
BP |
GO:0006508 |
proteolysis |
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. |
IDA|TAS |
|
BP |
GO:0006979 |
response to oxidative stress |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. |
IEA |
|
BP |
GO:0008584 |
male gonad development |
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure. |
IEA |
|
BP |
GO:0009612 |
response to mechanical stimulus |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
IEA |
|
BP |
GO:0009725 |
response to hormone |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus. |
IEA |
|
BP |
GO:0010831 |
positive regulation of myotube differentiation |
Any process that increases the frequency, rate or extent of myotube differentiation. Myotube differentiation is the process in which a relatively unspecialized cell acquires specialized features of a myotube cell. Myotubes are multinucleated cells that are formed when proliferating myoblasts exit the cell cycle, differentiate and fuse. |
ISS |
|
BP |
GO:0010952 |
positive regulation of peptidase activity |
Any process that increases the frequency, rate or extent of peptidase activity, the hydrolysis of peptide bonds within proteins. |
IEA |
|
BP |
GO:0014070 |
response to organic cyclic compound |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus. |
IEA |
|
BP |
GO:0016485 |
protein processing |
Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. |
TAS |
|
BP |
GO:0022617 |
extracellular matrix disassembly |
A process that results in the breakdown of the extracellular matrix. |
TAS |
|
BP |
GO:0030307 |
positive regulation of cell growth |
Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
IDA |
|
BP |
GO:0030324 |
lung development |
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. |
IEA |
|
BP |
GO:0030335 |
positive regulation of cell migration |
Any process that activates or increases the frequency, rate or extent of cell migration. |
IDA |
|
BP |
GO:0030574 |
collagen catabolic process |
The proteolytic chemical reactions and pathways resulting in the breakdown of collagen in the extracellular matrix, usually carried out by proteases secreted by nearby cells. |
TAS |
|
BP |
GO:0031638 |
zymogen activation |
The proteolytic processing of an inactive enzyme to an active form. |
IEA |
|
BP |
GO:0035987 |
endodermal cell differentiation |
The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo. |
IEP |
|
BP |
GO:0035988 |
chondrocyte proliferation |
The multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage. |
IEA |
|
BP |
GO:0043615 |
astrocyte cell migration |
The orderly movement of an astrocyte, a class of large neuroglial (macroglial) cells in the central nervous system, the largest and most numerous neuroglial cells in the brain and spinal cord. |
IEA |
|
BP |
GO:0043627 |
response to estrogen |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. |
IEA |
|
BP |
GO:0045579 |
positive regulation of B cell differentiation |
Any process that activates or increases the frequency, rate or extent of B cell differentiation. |
ISS |
|
BP |
GO:0045746 |
negative regulation of Notch signaling pathway |
Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway. |
ISS |
|
BP |
GO:0048701 |
embryonic cranial skeleton morphogenesis |
The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase. |
IEA |
|
BP |
GO:0048754 |
branching morphogenesis of an epithelial tube |
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder. |
IEA |
|
BP |
GO:0048771 |
tissue remodeling |
The reorganization or renovation of existing tissues. This process can either change the characteristics of a tissue such as in blood vessel remodeling, or result in the dynamic equilibrium of a tissue such as in bone remodeling. |
IEA |
|
BP |
GO:0048870 |
cell motility |
Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another. |
TAS |
|
BP |
GO:0051895 |
negative regulation of focal adhesion assembly |
Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions. |
IEA |
|
BP |
GO:0097094 |
craniofacial suture morphogenesis |
The process in which any suture between cranial and/or facial bones is generated and organized. |
IEA |
|
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
|
CC |
GO:0005796 |
Golgi lumen |
The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks. |
TAS |
|
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
IDA|TAS |
|
CC |
GO:0005887 |
integral component of plasma membrane |
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
TAS |
|
CC |
GO:0005925 |
focal adhesion |
Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
IDA |
|
CC |
GO:0031012 |
extracellular matrix |
A structure lying external to one or more cells, which provides structural support for cells or tissues. |
IEA |
|
CC |
GO:0031410 |
cytoplasmic vesicle |
A vesicle found in the cytoplasm of a cell. |
IDA |
|
CC |
GO:0042470 |
melanosome |
A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells. |
IEA |
|
CC |
GO:0044354 |
macropinosome |
A membrane-bounded, uncoated intracellular vesicle formed by the process of macropinocytosis. |
IDA |
|
MF |
GO:0004222 |
metalloendopeptidase activity |
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. |
ISS |
|
MF |
GO:0004252 |
serine-type endopeptidase activity |
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine). |
TAS |
|
MF |
GO:0005178 |
integrin binding |
Interacting selectively and non-covalently with an integrin. |
IEA |
|
MF |
GO:0005509 |
calcium ion binding |
Interacting selectively and non-covalently with calcium ions (Ca2+). |
IEA |
|
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
|
MF |
GO:0008270 |
zinc ion binding |
Interacting selectively and non-covalently with zinc (Zn) ions. |
IEA |
|
MF |
GO:0016504 |
peptidase activator activity |
Binds to and increases the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds. |
IEA |
|
MF |
GO:0070006 |
metalloaminopeptidase activity |
Catalysis of the hydrolysis of N-terminal amino acid residues from a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions. |
IDA|TAS |
| Domain ID | Description |
|---|---|
|
IPR000585 |
Hemopexin-like domain |
|
IPR001818 |
Peptidase M10, metallopeptidase |
|
IPR002477 |
Peptidoglycan binding-like |
|
IPR006026 |
Peptidase, metallopeptidase |
|
IPR016293 |
Peptidase M10A, stromelysin-type |
|
IPR018486 |
Hemopexin, conserved site |
|
IPR018487 |
Hemopexin-like repeats |
|
IPR021158 |
Peptidase M10A, cysteine switch, zinc binding site |
|
IPR021190 |
Peptidase M10A |
|
IPR021805 |
Peptidase M10A, matrix metallopeptidase, C-terminal |
|
IPR024079 |
Metallopeptidase, catalytic domain |
|
IPR028693 |
Matrix metalloproteinase-14 |
|
IPR033739 |
Peptidase M10A, catalytic domain |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
|
hsa04668 |
TNF signaling pathway |
KEGG |
|
hsa04912 |
GnRH signaling pathway |
KEGG |
|
WP2324 |
AGE/RAGE pathway |
WikiPathways |
|
WP615 |
Senescence and Autophagy in Cancer |
WikiPathways |
|
WP129 |
Matrix Metalloproteinases |
WikiPathways |
|
WP3888 |
VEGFA-VEGFR2 Signaling Pathway |
WikiPathways |
|
h_reckPathway |
Inhibition of Matrix Metalloproteinases |
BioCarta |
| UMLS CUI | UMLS Term |
|---|---|
|
C0001418 |
Adenocarcinoma |
|
C0014859 |
Esophageal Neoplasms |
|
C0024117 |
Chronic Obstructive Airway Disease |
|
C0027626 |
Neoplasm Invasiveness |
|
C0162871 |
Aortic Aneurysm, Abdominal |
|
C1458155 |
Mammary Neoplasms |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
|
PRKCD |
5580 |
Q05655 |
0.00 |
|
ENG |
2022 |
P17813 |
0.49 |
|
ACTB |
60 |
P60709 |
0.52 |
|
CAV1 |
857 |
Q03135 |
0.52 |
|
F12 |
2161 |
P00748 |
0.52 |
|
GOLGB1 |
2804 |
Q14789 |
0.52 |
|
ITGAV |
3685 |
P06756 |
0.52 |
|
MMP13 |
4322 |
P45452 |
0.52 |
|
TIMP3 |
7078 |
P35625 |
0.52 |
|
KISS1 |
3814 |
Q15726 |
0.55 |
|
MMP2 |
4313 |
P08253 |
0.62 |
|
FURIN |
5045 |
P09958 |
0.63 |
|
RRAD |
6236 |
P55042 |
0.63 |
|
PLLP |
51090 |
Q9Y342 |
0.63 |
|
CCDC155 |
147872 |
Q8N6L0 |
0.63 |
|
LIMK1 |
3984 |
P53667 |
0.65 |
|
CCL7 |
6354 |
P80098 |
0.65 |
|
SDC1 |
6382 |
P18827 |
0.65 |
|
GORASP2 |
26003 |
Q9H8Y8 |
0.65 |
|
LRP1 |
4035 |
Q07954 |
0.73 |
|
BCAR1 |
9564 |
P56945 |
0.73 |
|
ADI1 |
55256 |
Q9BV57 |
0.76 |
|
C1QBP |
708 |
Q07021 |
0.87 |
|
LUM |
4060 |
P51884 |
0.87 |
|
TIMP2 |
7077 |
P16035 |
0.96 |
|
EGF |
1950 |
P01133 |
0.00 |
|
FN1 |
2335 |
P02751 |
0.00 |
|
SPOCK1 |
6695 |
Q08629 |
0.52 |
|
TIMP4 |
7079 |
Q99727 |
0.52 |
|
CLDN1 |
9076 |
O95832 |
0.52 |
|
TGOLN2 |
10618 |
O43493 |
0.52 |
|
EGFR |
1956 |
P00533 |
0.63 |
|
ACAN |
176 |
P16112 |
0.65 |
|
SPOCK3 |
50859 |
Q9BQ16 |
0.73 |